Enhancement of DNA vaccine potency using conventional aluminum adjuvants

Vaccine

Volumn 18, Issue 1-2, 1999, Pages 18-28

  Ulmer, J B ^a   Dewitt, C M ^a   Chastain, M ^a   Friedman, A ^a   Donnelly, J J ^a   McClements, W L ^a   Caulfield, M J ^a   Bohannon, K E ^a   Volkin, D B ^a   Evans, R K ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adjuvant; DNA vaccine; Herpes simplex virus; Influenza

Indexed keywords

ALUMINUM SALT; DNA VACCINE; PLASMID DNA;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DNA BINDING; GUINEA PIG; IMMUNOGENICITY; INFECTION; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; FEMALE; GUINEA PIGS; MACACA MULATTA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PAN TROGLODYTES; PHOSPHATES; VACCINES, DNA;

EID: 0033588543     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00151-6     Document Type: Article

References (38)

1. Donnelly J.J., Ulmer J.B., Liu M.L. Recombinant vaccines: Technology and applications. Exp Opin Ther Patents. 5:1995;211-217.
2. Benvenisty N., Reshef L. Direct introduction of genes into rats and expression of the genes. Proc Natl Acad Sci USA. 83:1986;9551-9555.
3. Wolff J., Malone R.W., Williams P., Chong W., Ascadi G., Jani A., Felgner P. Direct transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
4. Tang D.C., De Vit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
5. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., De Witt C.M., Friedman A., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
6. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Ann Rev Immunol. 15:1997;617-648.
7. Calarota S., Bratt G., Nordlund S., Hinkula J., Leandersson A., Sandstrom E., Wahren B. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet. 351:1998;1320-1325.
8. Wang R., Doolan D., Le T., Hedstrom R., Coonan K., Charoenvit Y., Jones T., Hobart P., Margalith M., Ng J., Weiss W., Sedegah M., de Taisne C., Norman J., Hoffman S. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.
9. MacGregor R., Boyer J., Ugen K., Lacy K., Gluckman S., Bagarazzi M., Chattergoon M., Baine Y., Higgins T., Ciccarelli R., Coney L., Ginsberg R., Weiner D. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis. 178:1998;92-100.
10. Xiang Z., Ertl H.C. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135.
11. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 158:1997;816-826.
12. Okada E., Sasaki S., Ishii N., Aoki T., Yasuda T., Nishioka J., Fukushima J., Miyazaki J., Wahren B., Okuda K.R.A. Intranasal immunization of a DNA vaccine with IL-12 and granulocyte macrophage colony stimulating factor (GM-CSF) expressing plasmids in liposomes induces strong mucosal and cell mediated immune responses agains HIV-1 antigens. J Immunol. 159:1997;3638-3647.
13. Tsuji T., Fukushima J., Hamajima K., Ishii N., Aoki I., Bukawa H., Ishigatsubo Y., Tani K., Okubo T., Dorf M.E., Okuda K. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology. 90:1997;1-6.
14. Tsuji T., Hamajima K., Ishii N., Aoki J., Fukushima K.Q., Xin S., Kawamoto S., Sasaki S., Matsunaga K., Ishigatsubo Y., Tani K., Okubo T., Okuda K. Immunomodulatroy effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur J Immunol. 27:1997;782-787.
15. Mendoza R.B., Cantwell M.J., Kipps T.J. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J Immunol. 159:1997;5777-5781.
16. Iwasaki A., Stiernholm B.J.N., Chan A.K., Berinstein N.L., Barber B.H. Enhanced cytotoxic T-lymphocyte responses mediated by plasmid DNA immunogens encoding co-stimulatory molecules and cytokines. J Immunol. 158:1997;4591-4601.
17. Toda S., Ishii N., Okada E., Kusakabe K.I., Arai H., Hamajima I., Gorai K., Nishioka K., Okuda K.R.A. HIV 1 specific cell mediated immune responses induced by DNA vaccination were enhanced by mmanan coated liposomes and inhibited by anti-interferon gamma antibody. Immunology. 92:1997;111-117.
18. Gregoriadis G., Safie R., de Souza J.B. Liposome-mediated DNA vaccination. FEBS Lett. 402:1997;107-110.
19. Ishii N., Fukushima J., Kaneko T., Okada E., Tani K., Tanaka S-I., Hamajima K., Xin K-Q., Kawamoto S., Koff W., Nishioka K., Yasuda T.K.O. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. Aids Res and Human Retroviruses. 13:1997;1421-1427.
20. Sasaki S., Takashi T., Hamajima K., Fukushima J., Ishii N., Kaneko T., Xin K-Q., Mohri H., Aoki I., Okubo T., Nishka K., Okuda K. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infection and Immunity. 65:1997;3520-3528.
21. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., Mohri H., Kensil C., Okuda K. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J Virol. 72:1998;4931-4939.
22. Warren H.S., Vogel F.R., Chedid L.A. Current status of immunological adjuvants. Ann Rev Immunol. 4:1986;369-388.
23. Hem S.L., White J.L. Structure and properties of aluminum-containing adjuvants. Powell M., Newman M. Vaccine design: The subunit and adjuvant approach. 1995;249-276 Plenum Press, New York.
24. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., Ulmer J.B., Donnelly J.J., Liu M.A. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:1993;777-783.
25. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA. 93:1996;11414-11420.
26. Ulmer J.B., Deck R.R., DeWitt C., Donnelly J., Liu M. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells. Immunology. 89:1996;59-67.
27. Bourne N., Stanberry L.R., Bernstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis. 173:1996;800-807.
28. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. The prophylactic effect of immunization with DNA encoding Herpes Simplex virus glycoproteins on HSV-induced disease in guinea pigs. Vaccine. 15:1997;857-860.
29. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med. 1:1995;583-587.
30. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine. 15:1997;71-78.
31. Glenny A.T., Pope C.G., Waddington H., Wallace U. Immunological Notes XXIII. The antigenic value of toxoid precipitated by potassium alum. J Pathol and Bacteriol. 29:1926;38-39.
32. Cox J.C., Coulter A.R. Adjuvants - a classification and review of their modes of action. Vaccine. 15:1997;248-256.
33. 26Al. Vaccine. 15:1997;1314-1318.
34. Gupta R.K., Rost B.E., Relyveld E., Siber G.R. Adjuvant properties of aluminum and calcium compounds. Pharm Biotechnol. 6:1995;229-248.
35. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med. 184:1996;1555-1560.
36. Fu T-M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., Liu X., Donnelly J.J., Liu M.A. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Molecular Medicine. 3:1997;362-371.
37. Iwasaki A., Torre C., Ohashi P., Robinson H., Barber B. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol. 159:1997;11-14.
38. Mancino D, Ovary Z, Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains. Int Arch Allergy Appl Immunol 1980;61 1980;253-8.